Gene expression of receptors for IL-6, LIF, and CNTF in regenerating skeletal muscles

被引:62
作者
Kami, K
Morikawa, Y
Sekimoto, M
Senba, E
机构
[1] Osaka Univ Hlth & Sport Sci, Dept Hlth Sci, Kumatori, Osaka 5900496, Japan
[2] Hokkaido Univ, Inst Med Genet, Div Immunoregulat, Sapporo, Hokkaido 060, Japan
[3] Wakayama Med Coll, Dept Anat & Neurobiol, Wakayama 640, Japan
关键词
leukemia inhibitory factor receptor beta; ciliary neurotrophic factor receptor alpha; interleukin-6 receptor alpha; gp130; muscle regeneration;
D O I
10.1177/002215540004800904
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The biological actions of interleukin-6 (IL-6), leukemia inhibitory factor (LIF), and ciliary neurotrophic factor (CNTF) are mediated via respective functional receptor complexes consisting of a common signal-transducing component, gp130, and other specific receptor components, IL-6 receptor alpha (IL-6R), LIF receptor beta (LIFR), and CNTF receptor alpha (CNTFR). IL-6, LIF, and CNTF are implicated in skeletal muscle regeneration. However, the cell populations that express these receptor components in regenerating muscles are unknown. Using in situ hybridization histochemistry, we examined spatiotemporal expression patterns of gp130 IL-6R, LIFR and CNTFR mRNAs in regenerating muscles after muscle contusion. At the early stages of regeneration (from 3 hr to Day 2 post contusion), significant signals for gp130 and LIFR mRNAs were detected in myonuclei and/or nuclei of muscle precursor cells (mpcs) and in mononuclear cells located in extracellular spaces between myofibers after muscle contusion, but IL-6R mRNA was expressed only in mononuclear cells. At Day 7 post contusion, signals for gp130, LIFR, and IL-6R mRNAs were not detected in newly formed myotubes, whereas the CNTFR mRNA level was upregulated in myotubes. These findings suggest that the upregulation of receptor subunits in distinct cell populations plays an important role in the effective regeneration of both myofibers and motor neurons.
引用
收藏
页码:1203 / 1213
页数:11
相关论文
共 35 条
[1]   EFFECTS OF LEUKEMIA INHIBITORY FACTOR AND OTHER CYTOKINES ON MURINE AND HUMAN MYOBLAST PROLIFERATION [J].
AUSTIN, L ;
BOWER, J ;
KUREK, J ;
VAKAKIS, N .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1992, 112 (1-2) :185-191
[2]   LEUKEMIA INHIBITORY FACTOR (LIF) INFUSION STIMULATES SKELETAL-MUSCLE REGENERATION AFTER INJURY - INJURED MUSCLE EXPRESSES LIF MESSENGER-RNA [J].
BARNARD, W ;
BOWER, J ;
BROWN, MA ;
MURPHY, M ;
AUSTIN, L .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1994, 123 (1-2) :108-113
[3]   Regulation of distinct stages of skeletal muscle differentiation by mitogen-activated protein kinases [J].
Bennett, AM ;
Tonks, NK .
SCIENCE, 1997, 278 (5341) :1288-1291
[4]   SPECIFIC BINDING OF LEUKEMIA INHIBITORY FACTOR TO MURINE MYOBLASTS IN CULTURE [J].
BOWER, J ;
VAKAKIS, N ;
NICOLA, NA ;
AUSTIN, L .
JOURNAL OF CELLULAR PHYSIOLOGY, 1995, 164 (01) :93-98
[5]   LEUKEMIA INHIBITORY FACTOR AND INTERLEUKIN-6 ARE EXPRESSED AT VERY-LOW LEVELS IN THE NORMAL ADULT-MOUSE AND ARE INDUCED BY INFLAMMATION [J].
BROWN, MA ;
METCALF, D ;
GOUGH, NM .
CYTOKINE, 1994, 6 (03) :300-309
[6]   RETROGRADE AXONAL-TRANSPORT OF CILIARY NEUROTROPHIC FACTOR IS INCREASED BY PERIPHERAL-NERVE INJURY [J].
CURTIS, R ;
ADRYAN, KM ;
ZHU, Y ;
HARKNESS, PJ ;
LINDSAY, RM ;
DISTEFANO, PS .
NATURE, 1993, 365 (6443) :253-255
[7]   RELEASED FORM OF CNTF RECEPTOR-ALPHA COMPONENT AS A SOLUBLE MEDIATOR OF CNTF RESPONSES [J].
DAVIS, S ;
ALDRICH, TH ;
IP, NY ;
STAHL, N ;
SCHERER, S ;
FARRUGGELLA, T ;
DISTEFANO, PS ;
CURTIS, R ;
PANAYOTATOS, N ;
GASCAN, H ;
CHEVALIER, S ;
YANCOPOULOS, GD .
SCIENCE, 1993, 259 (5102) :1736-1739
[8]   INTERLEUKIN-6 INDUCES PROTEOLYSIS BY ACTIVATING INTRACELLULAR PROTEASES (CATHEPSIN-B AND CATHEPSIN-L, PROTEASOME) IN C2C12 MYOTUBES [J].
EBISUI, C ;
TSUJINAKA, T ;
MORIMOTO, T ;
KAN, K ;
IIJIMA, S ;
YANO, M ;
KOMINAMI, E ;
TANAKA, K ;
MONDEN, M .
CLINICAL SCIENCE, 1995, 89 (04) :431-439
[9]   Induction of embryonic vasculogenesis by bFGF and LIF in vitro and in vivo [J].
Gendron, RL ;
Tsai, FY ;
Paradis, H ;
Arceci, RJ .
DEVELOPMENTAL BIOLOGY, 1996, 177 (01) :332-346
[10]  
GOODMAN MN, 1994, P SOC EXP BIOL MED, V205, P182